INFORMACIÓN ACADÉMICA Y ADMISIONES

Credits - 30 / European ECTS credits

Pre-selection process: Open

Inscriptions Open: from June 2019 to January 2020

Postgraduate Program –  from the 3rd of February 2019 to the  28th of May 2019.

Full Time - Monday to Thursday from 18:00h. to 21:00h.

Language - English

Limited Places

OBJETIVOS DEL POSTGRADO

The objective of the program is to acquire a specialized knowledge in corporate finance and corporate law in late stage negotiation agreements between pharma and biotech in portfolio management. The main skills and topics are related with international negotiation processes in licensing agreements or merge and acquisitions, corporate finance and corporate law for the deal head establishment, upfront and milestones.

Ver el programa acádemico

DESARROLLO PROFESIONAL

The students of our master programs will have the opportunity to work in teams of some of the most important global pharmaceutical companies as well as new biotechnology companies, developing innovative products inside the biomedical sector. Their demanded profiles allow the students to work in different roles and departments in biotech companies, consultancies, pharmaceutical companies, technology transfer offices from hospitals and research centers. 

TITULACIÓN DEL POSTGRADO

Los estudiantes que aprueben el programa recibirán una doble titulación de la Universidad de Barcelona y del Instituto Empresarial de Biotecnologia en Postgrado de Especialización en Licencias  y Gestión de Portfolios.

                


 

Solicitud de información